BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 37817377)

  • 1. Stimulatory Anticancer Effect of Resveratrol Mediated by G Protein-Coupled Estrogen Receptor in Colorectal Cancer.
    Kim N; Kwon J; Shin US; Jung J
    Biomol Ther (Seoul); 2023 Nov; 31(6):655-660. PubMed ID: 37817377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic down regulation of G protein-coupled estrogen receptor (GPER) functions as a tumor suppressor in colorectal cancer.
    Liu Q; Chen Z; Jiang G; Zhou Y; Yang X; Huang H; Liu H; Du J; Wang H
    Mol Cancer; 2017 May; 16(1):87. PubMed ID: 28476123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPER mediates differential effects of estrogen on colon cancer cell proliferation and migration under normoxic and hypoxic conditions.
    Bustos V; Nolan ÁM; Nijhuis A; Harvey H; Parker A; Poulsom R; McBryan J; Thomas W; Silver A; Harvey BJ
    Oncotarget; 2017 Oct; 8(48):84258-84275. PubMed ID: 29137421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GPER Agonist G1 Prevents Wnt-Induced
    Abancens M; Harvey BJ; McBryan J
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen Activation by Steroid Sulfatase Increases Colorectal Cancer Proliferation via GPER.
    Gilligan LC; Rahman HP; Hewitt AM; Sitch AJ; Gondal A; Arvaniti A; Taylor AE; Read ML; Morton DG; Foster PA
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4435-4447. PubMed ID: 28945888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells.
    Yu T; Liu M; Luo H; Wu C; Tang X; Tang S; Hu P; Yan Y; Wang Z; Tu G
    J Steroid Biochem Mol Biol; 2014 Sep; 143():392-403. PubMed ID: 24874276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G protein-coupled estrogen receptor in colon function, immune regulation and carcinogenesis.
    Jacenik D; Beswick EJ; Krajewska WM; Prossnitz ER
    World J Gastroenterol; 2019 Aug; 25(30):4092-4104. PubMed ID: 31435166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The G-protein-coupled estrogen receptor, a gene co-expressed with ERα in breast tumors, is regulated by estrogen-ERα signalling in ERα positive breast cancer cells.
    Pal U; Manjegowda MC; Singh N; Saikia S; Philip BS; Jyoti Kalita D; Kumar Rai A; Sarma A; Raphael V; Modi D; Chandra Kataki A; Mukund Limaye A
    Gene; 2023 Aug; 877():147548. PubMed ID: 37279863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. G Protein-Coupled Estrogen Receptor Mediates Cell Proliferation through the cAMP/PKA/CREB Pathway in Murine Bone Marrow Mesenchymal Stem Cells.
    Chuang SC; Chen CH; Chou YS; Ho ML; Chang JK
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32899453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic GPER activation prompted the proliferation of ileal stem cell in ovariectomized mice depending on Paneth cell-derived Wnt3.
    Liu J; Liu K; Chai S; Xu R; Wang Y; Zhang Y; Wang S; Liu C; Xue B
    Clin Sci (Lond); 2023 Jan; 137(1):109-127. PubMed ID: 36503938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
    Zekas E; Prossnitz ER
    BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Androgen Receptor Promotes Cellular Proliferation by Suppression of G-Protein Coupled Estrogen Receptor Signaling in Triple-Negative Breast Cancer.
    Shen Y; Yang F; Zhang W; Song W; Liu Y; Guan X
    Cell Physiol Biochem; 2017; 43(5):2047-2061. PubMed ID: 29059676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPER-Induced ERK Signaling Decreases Cell Viability of Hepatocellular Carcinoma.
    Qiu YA; Xiong J; Fu Q; Dong Y; Liu M; Peng M; Jin W; Zhou L; Xu X; Huang X; Fu A; Xu G; Tu G; Yu T
    Front Oncol; 2021; 11():638171. PubMed ID: 33767999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
    He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
    Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines.
    Skrzypczak M; Schüler S; Lattrich C; Ignatov A; Ortmann O; Treeck O
    Steroids; 2013 Nov; 78(11):1087-91. PubMed ID: 23921077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells.
    Shi D; Zhao P; Cui L; Li H; Sun L; Niu J; Chen M
    BMC Pharmacol Toxicol; 2020 May; 21(1):32. PubMed ID: 32357920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
    Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
    Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel estrogen receptor GPER mediates proliferation induced by 17β-estradiol and selective GPER agonist G-1 in estrogen receptor α (ERα)-negative ovarian cancer cells.
    Liu H; Yan Y; Wen H; Jiang X; Cao X; Zhang G; Liu G
    Cell Biol Int; 2014 May; 38(5):631-8. PubMed ID: 24446390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ER-mediated anti-tumor effects of shikonin on breast cancer.
    Yang Y; Gao W; Tao S; Wang Y; Niu J; Zhao P; Rao C; Yang L
    Eur J Pharmacol; 2019 Nov; 863():172667. PubMed ID: 31545985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
    Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
    Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.